UB Paderborn / Katalog / Suche / in CDI

Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain

Blood, 2013-08, Vol.122 (9), p.1634-1648

2013

Link zum Volltext

Verfügbarkeit prüfen

Droplet Digital PCR for BCR–ABL1 Monitoring in Diagnostic Routine: Ready to Start?

Cancers, 2021-10, Vol.13 (21), p.5470

2021

Link zum Volltext

Verfügbarkeit prüfen

Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia

Frontiers in oncology, 2021-09, Vol.11

2021

Link zum Volltext

Verfügbarkeit prüfen

Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights

Cells (Basel, Switzerland), 2023-06, Vol.12 (13), p.1703

2023

Link zum Volltext

Verfügbarkeit prüfen

PB1865: NPM1‐MUT MONITORING DURING GILTERITINIB TREATMENT IDENTIFIES DIFFERENT DYNAMICAL PATTERNS IN RESPONSIVE PATIENTS

HemaSphere, 2023-08, Vol.7 (S3), p.e3793940-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report

BMC cancer, 2017-08, Vol.17 (1), p.523-523, Article 523

2017

Link zum Volltext

Verfügbarkeit prüfen

A Human Neurovascular Unit On-a-Chip

Methods in molecular biology (Clifton, N.J.), 2022, Vol.2373, p.107

2022

Link zum Volltext

Verfügbarkeit prüfen

Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia

Leukemia, 2022-09, Vol.36 (9), p.2250-2260

2022

Link zum Volltext

Verfügbarkeit prüfen

Recurrent Gastrointestinal Hemorrhage in Treatment with Dasatinib in a Patient Showing SMAD4 Mutation with Acute Lymphoblastic Leukemia Philadelphia Positive and Juvenile Polyposis Hereditary Hemorrhagic Telangiectasia Syndrome

Hematology reports, 2013-07, Vol.5 (2), p.26-e7

2013

Link zum Volltext

Verfügbarkeit prüfen

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study

Leukemia, 2022-07, Vol.36 (7), p.1834-1842

2022

Link zum Volltext

Verfügbarkeit prüfen

A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia

Blood, 2019-11, Vol.134 (Supplement_1), p.2092-2092

2019

Link zum Volltext

Verfügbarkeit prüfen

One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study

Blood, 2016-12, Vol.128 (22), p.5423-5423

2016

Link zum Volltext

Verfügbarkeit prüfen

Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients

Oncotarget, 2015-10, Vol.6 (31), p.31284-31294

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacological interaction and side effects in oncohaematology: a retrospective observational study

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18235-e18235

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1766: Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1766-1766

2017

Link zum Volltext

Verfügbarkeit prüfen

Backtracking BCR-ABL1 Mutants in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Relapsing on Tyrosine Kinase Inhibitors with Deep Sequencing: Implications for Routine Mutation Testing

Blood, 2014-12, Vol.124 (21), p.2259-2259

2014

Link zum Volltext

Verfügbarkeit prüfen

Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR)

Blood, 2016-12, Vol.128 (22), p.3096-3096

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract B03: Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome

Clinical cancer research, 2015-09, Vol.21 (17_Supplement), p.B03-B03

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response

Leukemia research, 2014-05, Vol.38 (5), p.581-585

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain

Droplet Digital PCR for BCR–ABL1 Monitoring in Diagnostic Routine: Ready to Start?

Case Report: A Novel Activating FLT3 Mutation in Acute Myeloid Leukemia

Prognosis in Chronic Myeloid Leukemia: Baseline Factors, Dynamic Risk Assessment and Novel Insights

PB1865: NPM1‐MUT MONITORING DURING GILTERITINIB TREATMENT IDENTIFIES DIFFERENT DYNAMICAL PATTERNS IN RESPONSIVE PATIENTS

The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report

PB1981: EXPERIENCE OF FOUR LABORATORIES OF THE ITALIAN CML LABNET NETWORK IN THE USE OF THE CEPHEID CARTRIDGE SYSTEM

A Human Neurovascular Unit On-a-Chip

Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia

Recurrent Gastrointestinal Hemorrhage in Treatment with Dasatinib in a Patient Showing SMAD4 Mutation with Acute Lymphoblastic Leukemia Philadelphia Positive and Juvenile Polyposis Hereditary Hemorrhagic Telangiectasia Syndrome

Drug resistance and BCR‐ABL kinase domain mutations in Philadelphia chromosome–positive acute lymphoblastic leukemia from the imatinib to the second‐generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study

A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia

An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease

Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients

One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study

Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients

Pharmacological interaction and side effects in oncohaematology: a retrospective observational study

Abstract 1766: Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients

Backtracking BCR-ABL1 Mutants in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Relapsing on Tyrosine Kinase Inhibitors with Deep Sequencing: Implications for Routine Mutation Testing

Clinical Relevance of Low Burden BCR-ABL1 Mutations Detectable By Amplicon Deep Sequencing (DS) in Philadelphia-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients (pts): The Type of Mutation Matters

Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR)

Abstract B03: Very poor outcome and chemoresistance of acute myeloid leukemia patients with TP53 mutations: Correlation with complex karyotype and clinical outcome

Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response

Suchergebnisse filtern